Waiver of protocol approval by phase for drugs, etc. eyed

Published: 2002-03-05 07:00:00

Updated: 2002-03-05 07:00:00

The approval of protocol by phase of drugs etc. is to be waived by the Korea Food and Drug Administration (KFDA), in order to introduce a prior consultation system and facilitate the R&D projects. Instead,, the KFDA says that the prior consultation system of drugs, etc. will be fully implemented ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK